Revision of USP <831> Refractive Index
Recommendation

27-29 October 2026
Practical Approaches for Assessing the Risks of Impurities
In the current Pharmacopeial Forum, PF 47(3), a proposal of USP Chapter <831> Refractive Index has been published for comments.
The proposal is based on the version of the chapter official prior to 2013. According to the USP, the previous proposal in PF 46(4) has been canceled, and the text has been revised to address comments received.
Besides minor editorial changes to update the chapter to the current USP style, the revisions to the chapter include the following:
- Add specification for an apparatus that provides a means of operation at the prescribed temperature with readings to at least ±0.1°.
- Add operational qualification requirements for accuracy that state the measurement of a certified reference material should agree with the stated certified value within the limits of the expanded uncertainty of the reference material added to the performance specification of the instrument.
- Clarify the performance qualification requirements.
- Remove the three replicate measurements of the sample from the Measurement Procedure section that was previously proposed in PF 46(4).
The deadline for submitting comments is July 31, 2021.
The draft chapter USP <831> Refractive Index can be viewed here. (Please note: a one-time registration is required to access the Pharmacopeial Forum.)
Related GMP News
19.10.2026EMA Updates Information Page on Bioequivalence Guidelines
19.10.2026BP Publishes new Draft Texts
19.10.2026FDA Identifies Critical Deficiencies in Analytical Testing and CGMP Oversight
07.10.2026Analytical Quality Group Developments May through August 2026
07.10.2026Two New FDA Warning Letters Put OOS Investigations in Focus
07.10.2026Pharmeuropa: Revision Proposed for Chapter 2.5.32 on Coulometric Karl Fischer Water Determination
